REGULATION OF SYSTEM Y(+) ARGININE TRANSPORT CAPACITY IN DIFFERENTIATING HUMAN INTESTINAL CACO-2 CELLS

被引:41
|
作者
PAN, M
MALANDRO, M
STEVENS, BR
机构
[1] UNIV FLORIDA, COLL MED, DEPT PHYSIOL, GAINESVILLE, FL 32610 USA
[2] UNIV FLORIDA, DEPT BIOCHEM & MOLEC BIOL, GAINESVILLE, FL 32610 USA
关键词
ARGININE; CACO-2; SMALL INTESTINE; CATIONIC AMINO ACID; MEMBRANE TRANSPORT; MCAT-1;
D O I
10.1152/ajpgi.1995.268.4.G578
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This study describes the ability of passaged human intestinal Caco-2 cells to regulate transport of L-arginine via system y(+). Subconfluent and confluent cells possessed system y(+) activity, as determined by the sodium independence of uptake and the pattern of inhibition by amino acid analogues or N-ethylmaleimide. Initial rates of arginine uptake via system y(+) decreased as the cells advanced from the undifferentiated to the differentiated state following culture passaging. Furthermore, kinetic analysis of the leucine-insensitive portion of uptake indicated that the Caco-2 system y(+) transport capacity decreased with cell age, dropping from a maximal velocity (V-max) = 1,094 pmol . mg(-1). min(-1) [Michaelis constant(K-m) = 41 mu M] in undifferentiated cells 2 days postseeding to V-max = 320 pmol . mg(-1). min(-1) (K, = 37 mu M) in confluent cells 9 days postseeding (from cells of the same passage). Northern analysis indicated that the levels of a single 7.9-kb mCAT-1 mRNA species were relatively constant over the course of Caco-2 differentiation and therefore were unsynchronized with the system y(+) relative transport activities. It is concluded that the Caco-2 capacity to transport arginine via system y(+) may be downregulated by posttransitional modifications in confluent cells compared with newly passaged undifferentiated cells. These data serve as a well-defined in vitro model for further studies regarding regulation of arginine transport in epithelial cells.
引用
收藏
页码:G578 / G585
页数:8
相关论文
共 50 条
  • [1] Dexamethasone regulation of taurine transport into human intestinal Caco-2 cells
    OFlaherty, L
    Stapleton, P
    Redmond, HP
    BouchierHayes, D
    JOURNAL OF LEUKOCYTE BIOLOGY, 1996, : 215 - 215
  • [2] Characterization and regulation of taurine transport in Caco-2, human intestinal cells
    Satsu, H
    Watanabe, H
    Arai, S
    Shimizu, M
    JOURNAL OF BIOCHEMISTRY, 1997, 121 (06): : 1082 - 1087
  • [3] REGULATION OF LYSOSOMAL AND UBIQUITIN DEGRADATIVE PATHWAYS IN DIFFERENTIATING HUMAN INTESTINAL CACO-2 CELLS
    ZHANG, Y
    WICK, DA
    HAAS, AL
    SEETHARAM, B
    DAHMS, NM
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1995, 1267 (01): : 15 - 24
  • [4] Transport of ginsenosides in human intestinal Caco-2 cells
    Li, WK
    Li, YM
    Fitzloff, JF
    van Breemen, RB
    DRUG METABOLISM REVIEWS, 2003, 35 : 157 - 157
  • [5] REGULATION OF AMINO-ACID-TRANSPORT IN DIFFERENTIATING INTESTINAL EPITHELIAL-CELLS IN CULTURE (CACO-2)
    PAN, M
    NEU, J
    STEVENS, BR
    FASEB JOURNAL, 1991, 5 (04): : A760 - A760
  • [6] System b0,+-mediated regulation of lysine transport in Caco-2 human intestinal cells
    Satsu, H
    Watanabe, H
    Arai, S
    Shimizu, M
    AMINO ACIDS, 1998, 14 (04) : 379 - 384
  • [7] System b0,+-mediated regulation of lysine transport in Caco-2 human intestinal cells
    H. Satsu
    H. Watanabe
    S. Arai
    M. Shimizu
    Amino Acids, 1998, 14 : 379 - 384
  • [8] Transport of parthenolide across human intestinal cells (Caco-2)
    Khan, SI
    Abourashed, EA
    Khan, IA
    Walker, LA
    PLANTA MEDICA, 2003, 69 (11) : 1009 - 1012
  • [9] Taxol transport by human intestinal epithelial Caco-2 cells
    Walle, UK
    Walle, T
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (04) : 343 - 346
  • [10] Resveratrol transport and metabolism by human intestinal Caco-2 cells
    Kaldas, MI
    Walle, UK
    Walle, T
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (03) : 307 - 312